Daré Bioscience mengadakan panggilan pendapatan untuk kuartal pertama tahun 2026 pada 14 Mei guna membahas hasil keuangan dan pembaruan bisnis yang berfokus pada produk kesehatan wanita.
Daré Bioscience, Inc. mengadakan panggilan konferensi pada pukul 16.30 EDT untuk membahas hasil untuk kuartal yang berakhir pada 31 Maret 2026. Chief Accounting Officer MarDee Haring-Layton membuka sesi tersebut dan memperkenalkan CEO Sabrina Johnson sebagai peserta utama di sampingnya.
Cytek Biosciences released its financial results for the first quarter of 2026 on May 7. The company then hosted an earnings conference call the same day at 4:30 PM EDT.
Dilaporkan oleh AI
BioMarin Pharmaceutical Inc. conducted its first-quarter 2026 earnings conference call on May 4, 2026. Company executives, including CEO Alexander Hardy, presented financial results and updates. The call included forward-looking statements and non-GAAP measures.
ImmunityBio, Inc. conducted its full year 2025 earnings conference call on March 3, 2026, at 4:30 PM EST. The call featured company leaders and analysts, with a standard disclaimer on forward-looking statements. A replay is available on the company's investor relations website.
Dilaporkan oleh AI
PureCycle Technologies conducted its first quarter 2026 corporate update conference call on May 6. The session featured the company's top executives reviewing recent developments.